| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 201.00B | 216.38B | 242.89B | 240.35B | 179.91B | 143.27B |
| Gross Profit | 30.98B | 33.73B | 37.17B | 34.24B | 25.64B | 20.60B |
| EBITDA | 12.04B | 12.75B | 14.88B | 13.03B | 8.86B | 5.23B |
| Net Income | 8.33B | 8.88B | 9.99B | 8.78B | 5.08B | 3.14B |
Balance Sheet | ||||||
| Total Assets | 158.33B | 157.60B | 163.35B | 143.75B | 108.05B | 91.45B |
| Cash, Cash Equivalents and Short-Term Investments | 5.64B | 8.38B | 6.87B | 6.54B | 5.13B | 5.68B |
| Total Debt | 34.83B | 42.63B | 52.10B | 45.65B | 29.48B | 25.40B |
| Total Liabilities | 108.24B | 108.59B | 117.16B | 104.75B | 76.03B | 61.80B |
| Stockholders Equity | 49.18B | 47.86B | 45.04B | 37.85B | 30.95B | 28.96B |
Cash Flow | ||||||
| Free Cash Flow | 17.15B | 17.36B | -602.00M | -12.46B | -1.27B | -3.89B |
| Operating Cash Flow | 17.40B | 18.91B | 301.00M | -12.19B | -891.00M | -3.46B |
| Investing Cash Flow | 860.00M | -2.07B | -2.69B | -199.00M | -155.00M | -469.00M |
| Financing Cash Flow | -22.36B | -15.25B | 2.53B | 13.75B | 606.00M | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.07T | 30.90 | 12.80% | 0.78% | 7.09% | 7.51% | |
78 Outperform | ¥299.79B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
75 Outperform | ¥1.14T | 19.48 | 11.14% | 1.46% | 3.92% | 9.99% | |
71 Outperform | ¥1.05T | 20.85 | 15.75% | 1.08% | 19.45% | 41.03% | |
70 Outperform | ¥98.16B | 10.19 | ― | 3.02% | -14.47% | -26.11% | |
62 Neutral | ¥458.56B | 19.19 | 5.63% | 2.35% | -9.06% | -35.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |